Cytokine Release by Peripheral Blood Lymphocytes Targeted with Bispecific Antibodies, and Its Role in Blocking Tumor Growth
- 1 December 1991
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 636 (1 Antigen ) , 288-294
- https://doi.org/10.1111/j.1749-6632.1991.tb33459.x
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Preliminary trial of specific targeting therapy against malignant gliomaThe Lancet, 1990
- In vivo localization of a bispecific antibody which targets human t lymphocytes to lyse human colon cancer cellsInternational Journal of Cancer, 1989
- Targeting of Cytotoxic Cells with Heterocrosslinked AntibodiesCancer Investigation, 1988
- Purified lymphocyte function-associated antigen 3 binds to CD2 and mediates T lymphocyte adhesion.The Journal of Experimental Medicine, 1987
- Two antigen-independent adhesion pathways used by human cytotoxic T-cell clonesNature, 1986
- Use of anti-receptor antibodies to focus T-cell activityImmunology Today, 1986
- Tumor Necrosis Factor (TNF)Science, 1985
- Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding proteinNature, 1985
- Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibodyNature, 1985
- Hybrid antibodies can target sites for attack by T cellsNature, 1985